Neurology and Neurosurgery

Episodes 1-16 of 364

• 

  CME/CE Meeting

  Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies

  July 30, 2025

  Toronto

  Learn more

• 

  RestartResume

  Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones

  RestartResume

  Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones

  NeuroFrontiers

  Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones

  • 

    

    John Golden

  • 

    

    Michael Greenberg, MD

• 

  RestartResume

  Prioritizing Patient-Centered, Multidisciplinary Care in CIDP

  RestartResume

  Prioritizing Patient-Centered, Multidisciplinary Care in CIDP

  Global Neurology Academy

  Prioritizing Patient-Centered, Multidisciplinary Care in CIDP

  • 

    

    Andrew G. Lee, MD

  • 

    

    Ashley Baker, MSN, PMHNP

• 

  RestartResume

  Transforming Clinician Wellness: EEG Headphones Helping with Burnout

  RestartResume

  Transforming Clinician Wellness: EEG Headphones Helping with Burnout

  NeuroFrontiers

  Transforming Clinician Wellness: EEG Headphones Helping with Burnout

  • 

    

    John Golden

  • 

    

    Michael Greenberg, MD

• 

  RestartResume

  Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation

  RestartResume

  Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation

  Global Neurology Academy

  Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation

  • 

    

    Nicolas Dubuisson, MD

  • 

    

    Ryan Quigley

• 

  RestartResume

  Spinal Muscular Atrophy Care: Optimizing Therapeutic Decision Making

  RestartResume

  Spinal Muscular Atrophy Care: Optimizing Therapeutic Decision Making

  NeuroFrontiers

  Spinal Muscular Atrophy Care: Optimizing Therapeutic Decision Making

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    John Brandsema, MD

• 

  RestartResume

  Gene Therapy Safety in DMD: How to Identify Common Immune Reactions

  RestartResume

  Gene Therapy Safety in DMD: How to Identify Common Immune Reactions

  NeuroFrontiers

  Gene Therapy Safety in DMD: How to Identify Common Immune Reactions

  • 

    

    Kaitlin Batley, MD

• 

  RestartResume

  Optimizing DMD Care Through Multidisciplinary Collaboration

  RestartResume

  Optimizing DMD Care Through Multidisciplinary Collaboration

  NeuroFrontiers

  Optimizing DMD Care Through Multidisciplinary Collaboration

  • 

    

    Kaitlin Batley, MD

• 

  RestartResume

  Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod

  RestartResume

  Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod

  NeuroFrontiers

  Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod

  • 

    

    Christopher A. Scheiner, MD, PhD

• 

  RestartResume

  Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates

  RestartResume

  Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates

  NeuroFrontiers

  Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates

• 

  RestartResume

  Managing MS in Older Adults: Top 5 Clinical Considerations

  RestartResume

  Managing MS in Older Adults: Top 5 Clinical Considerations

  NeuroFrontiers

  Managing MS in Older Adults: Top 5 Clinical Considerations

  • 

    

    Yinan Zhang, MD

• 

  RestartResume

  Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies

  RestartResume

  Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies

  Global Neurology Academy

  Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies

  • 

    

    Danielle Minetti

  • 

    

    Ryan Quigley

• 

  RestartResume

  New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies

  RestartResume

  New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies

  Global Neurology Academy

  New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies

  • 

    

    Chafic Karam, MD

  • 

    

    Ryan Quigley

• 

  RestartResume

  Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use

  RestartResume

  Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use

  NeuroFrontiers

  Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use

  • 

    

    Richard Nowak, MD, MS

• 

  RestartResume

  The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?

  RestartResume

  The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?

  CME/CE

  The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?

  1.00 credit

  • 

    

    Alejandro A. Rabinstein, MD, FAHA

  • 

    

    Richard E. Pratley, MD

  • 

    

    Jay H. Shubrook, DO, FACOFP, FAAFP

  1.00 credit

• 

  RestartResume

  Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools

  RestartResume

  Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools

  NeuroFrontiers

  Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools

  • 

    

    Riley Bove, MD, MMSc

• Prev
• 1
• 2
• 3
• …
• 22
• 23
• Next